These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 19266340)
1. Generation of Cre recombinase-expressing transgenic mice using bacterial artificial chromosomes. Parkitna JR; Engblom D; Schütz G Methods Mol Biol; 2009; 530():325-42. PubMed ID: 19266340 [TBL] [Abstract][Full Text] [Related]
2. Inducible gene inactivation in neurons of the adult mouse forebrain. Erdmann G; Schütz G; Berger S BMC Neurosci; 2007 Aug; 8():63. PubMed ID: 17683525 [TBL] [Abstract][Full Text] [Related]
3. Transgenic mice expressing Cre-recombinase specifically in retinal rod bipolar neurons. Zhang XM; Chen BY; Ng AH; Tanner JA; Tay D; So KF; Rachel RA; Copeland NG; Jenkins NA; Huang JD Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3515-20. PubMed ID: 16186328 [TBL] [Abstract][Full Text] [Related]
4. Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens. Jin C; McKeehan K; Wang F Prostate; 2003 Oct; 57(2):160-4. PubMed ID: 12949940 [TBL] [Abstract][Full Text] [Related]
5. Endothelium-specific Cre recombinase activity in flk-1-Cre transgenic mice. Licht AH; Raab S; Hofmann U; Breier G Dev Dyn; 2004 Feb; 229(2):312-8. PubMed ID: 14745955 [TBL] [Abstract][Full Text] [Related]
6. Efficient removal of loxP-flanked DNA sequences in a gene-targeted locus by transient expression of Cre recombinase in fertilized eggs. Sunaga S; Maki K; Komagata Y; Ikuta K; Miyazaki JI Mol Reprod Dev; 1997 Feb; 46(2):109-13. PubMed ID: 9021742 [TBL] [Abstract][Full Text] [Related]
7. Site- and time-specific gene targeting in the mouse. Metzger D; Chambon P Methods; 2001 May; 24(1):71-80. PubMed ID: 11327805 [TBL] [Abstract][Full Text] [Related]
8. Targeting mammary epithelial cells using a bacterial artificial chromosome. Wintermantel TM; Mayer AK; Schütz G; Greiner EF Genesis; 2002 Jul; 33(3):125-30. PubMed ID: 12124945 [TBL] [Abstract][Full Text] [Related]
9. Highly B lymphocyte-specific tamoxifen inducible transgene expression of CreER T2 by using the LC-1 locus BAC vector. Boross P; Breukel C; van Loo PF; van der Kaa J; Claassens JW; Bujard H; Schönig K; Verbeek JS Genesis; 2009 Nov; 47(11):729-35. PubMed ID: 19621440 [TBL] [Abstract][Full Text] [Related]
10. Generation of Pax2-Cre mice by modification of a Pax2 bacterial artificial chromosome. Ohyama T; Groves AK Genesis; 2004 Apr; 38(4):195-9. PubMed ID: 15083520 [TBL] [Abstract][Full Text] [Related]
11. Beta cell-specific ablation of target gene using Cre-loxP system in transgenic mice. Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC J Surg Res; 1999 Jun; 84(2):199-203. PubMed ID: 10357920 [TBL] [Abstract][Full Text] [Related]
13. An efficient system for tissue-specific overexpression of transgenes in podocytes in vivo. Moeller MJ; Soofi A; Sanden S; Floege J; Kriz W; Holzman LB Am J Physiol Renal Physiol; 2005 Aug; 289(2):F481-8. PubMed ID: 15784842 [TBL] [Abstract][Full Text] [Related]
14. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2. Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885 [TBL] [Abstract][Full Text] [Related]